A clinical trial evaluating the impact of EGCG on the length of recombinant tissue plasminogen activator therapy window in stroke patients found that patients with delayed onset-to-treatment time had better treatment outcomes after receiving EGCG
281 , L887L894 (2001)
First identified in human plasma, GHK-Cu levels naturally decline with age, which has made it a subject of significant research interest
Glycolic Acid gently exfoliates & smoothens skin
Therefore, FreSHtracer enables the selective sorting of highly functional stem cells based on GSH levels, regardless of donor age, which may help to overcome one of the main limitations of stem cell therapy
At TruMed, our goal is to understand the underlying factors that may be contributing to your health concerns and determine which combination of evidence-informed therapies, lifestyle strategies, and supportive treatments may be appropriate for your individual needs